This article was originally published in The Gray Sheet
Executive SummaryInteragency Council on Biomedical Imaging in Oncology, including representatives from FDA, the Health Care Financing Administration, and the National Institutes of Health's National Cancer Institute, will hold its next meeting Nov. 20, NIH says. The multi-agency group, which had its inaugural meeting in July as a sounding board for advice to investigators and manufacturers seeking to market new imaging technology, is accepting requests to be heard until Oct. 9. The council had reviewed 18 requests from large and small firms, as well as from members of academia. The meeting is closed to the public
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.